Finland at risk of losing pharmaceutical investments to its neighbors
According to a recent report, Finland has good opportunities to attract investments in the pharmaceutical and health sectors, but the country is at risk of falling behind its Nordic competitors. Although Finland possesses strong expertise, investments are currently often directed to other countries.
The report emphasizes that Finland's strengths include a high level of education and a high-quality research environment. Nevertheless, private research and development activities, pharmaceutical production, and clinical drug trials have not grown as hoped. Competition for international investments is fierce, and other Nordic countries have succeeded in creating a more attractive operating environment for companies.
According to experts, Finland should improve its operating conditions in order to compete on equal terms with its neighbors. This would require investments, particularly in research collaboration and streamlined regulation, which would help companies invest in Finland.
Pharmaceutical investments would bring not only new jobs to Finland, but also valuable expertise and economic growth. Developing the sector is important so that Finland can keep pace with international health sector developments and ensure patients' access to the latest treatments in the future.